Skip to main content
. 2020 Sep 4;4(11):bvaa131. doi: 10.1210/jendso/bvaa131

Table 1.

Clinical Characteristics of Patients with Congenital Adrenal Hyperplasia Compared With Controlsa

CAH Patients (n = 36) Controls (n = 27) P-Value
Age (years) 28.5 [22.3–35.8] 28.0 [23.0–31.0] 0.498
BMI (kg/m2) 29.4 [22.6–35.5] 24.5 [21.6–28.4] 0.013
Marital Status (# married, %) 9 (25%) 4 (14.8%) 0.323
Race (#, %)
 White 28 (77.8%) 23 (85.2%) 0.218
 Black or African American 3 (8.3%) 4 (14.8%)
 Multiple Races 1 (2.8%) 0
 Unknown 4 (11.1%) 0
Ethnicity (#, %)
 Not Latino or Hispanic 29 (80.5%) 26 (96.3%) 0.172
 Latino or Hispanic 6 (16.7%) 1 (3.7%)
 Unknown 1 (2.8%) 0
Gender a (#, %)
 Female 34 (94.4%) 26 (96.3%)
 Male 1 (2.8%) 0 0.671
 Other 1 (2.8%) 1 (3.7%)
Disease Control (# in control, %) b 28 (77.8%) N/A
Sexual Preference (#, %)
 Men 22 (61.1%) 26 (96.3%) 0.013
 Women 6 (16.7%) 0
 Both 6 (16.7%) 1 (3.7%)
 Neither/Asexual 2 (5.5%) 0
Sexual Activity
 Ever Sexually Active (#, %) 26 (72.2%) 27 (100%) 0.003
 # of Partners (#) 1 [0–4] c 8 [4–12] 0.013
Age of Menarche (years) 13 [12–15] 12 [12–13] 0.067
Regular Menses (#, %) 15 (41.7%) 24 (88.9%) <0.001
Pregnancy in Sexually Active (#, %) 6 (23.1%) 4 (14.8%) 0.442
Contraception Use in Sexually Active (#, %)
 Past 22 (84.6%) 26 (96.3%) 0.146
 Present 12 (46.2%) 22 (81.5%) 0.007
 Hormonal 21 (80.8%) 25 (92.6%) 0.204

Median [interquartile range] unless otherwise specified.

a Controls were age-, race-, and marital status–matched.

b Good disease control defined as androstenedione within reference range.

c n = 35 patients responded.